Literature DB >> 3075915

Is HLA matching relevant in pancreas transplantation? A registry analysis.

J P Squifflet1, K Moudry, D E Sutherland.   

Abstract

The International Pancreas Transplant Registry data base was analyzed for the effect of HLA and mismatching on pancreas survival rate. Typing data was available for both donor and recipient at the A, B and DR loci in 524 of 855 cadaver cases reported since 1982 and in 37 related cases. For cadaver cases, the 1-year functional survival rates for grafts mismatched at less than or equal to 3 (N = 163) versus greater than or equal to 4 (N = 361) A, B and DR antigens were 49% versus 39% (P = 0.121); for technically successful (TS) cases the rates were 66% (N = 123) versus 54% (N = 257) (P = 0.038). An effect was seen at A, B and DR loci, but the differences were not significant when considered separately. THe analysis of TS related donor transplants showed a 1-year graft survival rate of 89% for HLA mismatched donors (N = 11) and of 80% for HLA identical donors (N = 11). The survival rate of the latter is significantly higher (P = 0.046) than that of the TS cadaver donor transplants (59% at 1 year, N = 361). The data suggest that the results of pancreas transplantation will be improved by minimizing HLA mismatches. However, a reanalysis with a more complete data base is needed before firm conclusions can be drawn.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3075915     DOI: 10.1007/bf00337845

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  5 in total

1.  Coming of age for pancreas transplantation.

Authors:  D E Sutherland
Journal:  West J Med       Date:  1989-03

2.  Report from the International Pancreas Transplant Registry.

Authors:  D E Sutherland
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

3.  A 10-year experience with 290 pancreas transplants at a single institution.

Authors:  D E Sutherland; D L Dunn; F C Goetz; W Kennedy; R C Ramsay; M W Steffes; S M Mauer; R Gruessner; K C Moudry-Munns; P Morel
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

4.  Stem cell therapy to treat diabetes mellitus.

Authors:  Chee Gee Liew; Peter W Andrews
Journal:  Rev Diabet Stud       Date:  2009-02-10

Review 5.  The Importance of HLA Assessment in "Off-the-Shelf" Allogeneic Mesenchymal Stem Cells Based-Therapies.

Authors:  Marta Kot; Monika Baj-Krzyworzeka; Rafał Szatanek; Aleksandra Musiał-Wysocka; Magdalena Suda-Szczurek; Marcin Majka
Journal:  Int J Mol Sci       Date:  2019-11-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.